Union Korea Pharm. Co. Ltd.
Union Korea Pharm. Co. Ltd. operates in Pharmaceuticals.
Union Korea Pharm. Co. Ltd. (080720) - Net Assets
Latest net assets as of : ₩- KRW
Based on the latest financial reports, Union Korea Pharm. Co. Ltd. (080720) has net assets worth ₩- KRW as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩-) and total liabilities (₩-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Union Korea Pharm. Co. Ltd. - Net Assets Trend (None–None)
This chart illustrates how Union Korea Pharm. Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Union Korea Pharm. Co. Ltd. (None–None)
The table below shows the annual net assets of Union Korea Pharm. Co. Ltd. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Union Korea Pharm. Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Union Korea Pharm. Co. Ltd. Competitors by Market Cap
The table below lists competitors of Union Korea Pharm. Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bioretec Oyj
HE:BRETECN0125
|
$16.83K |
|
Megawide Construction Corp Preferred
PSE:MWP4
|
$16.85K |
|
abrdn European Logistics Income PLC
LSE:ASLI_old
|
$16.85K |
|
Sangsin Brake Co. Ltd.
KQ:041650
|
$16.85K |
|
Fauji Fertilizer Company Ltd
KAR:FFC
|
$16.82K |
|
Clearford Water Systems Inc
PINK:CLIRF
|
$16.81K |
|
CHWRD
PINK:CHWRD
|
$16.80K |
|
Crown LNG Holdings Limited Ordinary Shares
NASDAQ:CGBS
|
$16.80K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Union Korea Pharm. Co. Ltd.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Union Korea Pharm. Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Union Korea Pharm. Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Union Korea Pharm. Co. Ltd.'s net assets metrics with peer companies in the Pharmaceuticals industry.
Industry Context
- Industry: Pharmaceuticals
- Average net assets among peers: $96,196,506,488
- Average return on equity (ROE) among peers: -9.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Union Korea Pharm. Co. Ltd. (080720) | ₩- | N/A | N/A | $16.82K |
| Sam Chun Dang Pharm. Co. Ltd (000250) | $114.32 Billion | 10.17% | 0.61x | $3.69 Billion |
| DongKoo Bio&Pharma Co. Ltd (006620) | $94.65 Billion | 9.66% | 0.53x | $57.77 Million |
| NatureCell Co.Ltd (007390) | $34.02 Billion | -9.48% | 0.55x | $37.82 Million |
| Sam-A Pharm. Co. Ltd (009300) | $148.92 Billion | 6.63% | 0.09x | $21.27 Million |
| Kyung Dong Pharmaceutical Co. Ltd (011040) | $257.20 Billion | 4.73% | 0.21x | $50.06 Million |
| WooGene B&G Co. Ltd (018620) | $26.51 Billion | -25.02% | 1.26x | $10.61 Million |
| Oscotec Inc (039200) | $28.83 Billion | -91.10% | 0.70x | $890.75 Million |
| EstechPharma Co. Ltd (041910) | $123.30 Billion | 5.58% | 0.09x | $50.99 Million |
| Komipharm International Co. Ltd (041960) | $93.39 Billion | -15.32% | 0.50x | $237.27 Million |
| Eagle Veterinary Technology Co.Ltd (044960) | $40.83 Billion | 8.91% | 0.29x | $20.48 Million |